A detailed history of Capital International Investors transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Capital International Investors holds 3,113,749 shares of PACB stock, worth $4.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,113,749
Previous 3,113,749 -0.0%
Holding current value
$4.27 Million
Previous $30.5 Million 61.77%
% of portfolio
0.0%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$8.23 - $13.93 $9.07 Million - $15.4 Million
-1,102,052 Reduced 26.14%
3,113,749 $26 Million
Q1 2023

May 15, 2023

SELL
$7.94 - $12.02 $15 Million - $22.6 Million
-1,883,880 Reduced 30.88%
4,215,801 $48.8 Million
Q4 2022

Feb 14, 2023

SELL
$5.67 - $11.2 $13.3 Million - $26.3 Million
-2,349,477 Reduced 27.81%
6,099,681 $49.9 Million
Q3 2022

Nov 14, 2022

SELL
$3.93 - $8.57 $12.3 Million - $26.8 Million
-3,126,338 Reduced 27.01%
8,449,158 $49 Million
Q2 2022

Aug 15, 2022

SELL
$4.02 - $10.43 $4.85 Million - $12.6 Million
-1,206,359 Reduced 9.44%
11,575,496 $51.2 Million
Q1 2022

May 16, 2022

BUY
$8.43 - $20.9 $5.69 Million - $14.1 Million
675,537 Added 5.58%
12,781,855 $116 Million
Q4 2021

Feb 14, 2022

BUY
$19.26 - $30.08 $13.7 Million - $21.4 Million
712,191 Added 6.25%
12,106,318 $248 Million
Q3 2021

Nov 15, 2021

BUY
$24.86 - $35.02 $65.1 Million - $91.6 Million
2,616,823 Added 29.81%
11,394,127 $291 Million
Q2 2021

Aug 16, 2021

BUY
$22.3 - $36.02 $18.7 Million - $30.3 Million
840,179 Added 10.59%
8,777,304 $307 Million
Q1 2021

May 14, 2021

SELL
$26.38 - $51.15 $49.4 Million - $95.7 Million
-1,870,901 Reduced 19.08%
7,937,125 $264 Million
Q4 2020

Feb 12, 2021

SELL
$10.5 - $28.5 $9.78 Million - $26.6 Million
-931,806 Reduced 8.68%
9,808,026 $254 Million
Q3 2020

Nov 13, 2020

BUY
$3.61 - $9.87 $14.2 Million - $38.9 Million
3,943,532 Added 58.02%
10,739,832 $106 Million
Q1 2020

May 15, 2020

BUY
$2.36 - $5.26 $3.57 Million - $7.97 Million
1,514,500 Added 28.67%
6,796,300 $20.8 Million
Q4 2019

Feb 18, 2020

BUY
$4.6 - $5.57 $24.3 Million - $29.4 Million
5,281,800 New
5,281,800 $27.1 Million
Q1 2019

May 15, 2019

SELL
$6.8 - $7.4 $14.1 Million - $15.4 Million
-2,080,000 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$3.99 - $7.82 $8.31 Million - $16.3 Million
-2,082,441 Reduced 50.03%
2,080,000 $15.4 Million
Q3 2018

Nov 14, 2018

BUY
$3.52 - $5.55 $14.7 Million - $23.1 Million
4,162,441 New
4,162,441 $22.5 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $308M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.